OM:BRAV
OM:BRAVCommercial Services

The Bull Case For Bravida Holding (OM:BRAV) Could Change Following Profitability Gains Despite Lower Sales – Learn Why

Bravida Holding AB (publ) recently reported third quarter and nine-month earnings for 2025, with sales reaching SEK 6,433 million and SEK 20,295 million respectively, and net income rising to SEK 244 million and SEK 739 million for the respective periods. Despite slightly lower sales, the company achieved higher net income and improved earnings per share, highlighting strengthened profitability for the latest periods. We’ll explore how this improvement in profitability may influence Bravida...
OM:GRNG
OM:GRNGMetals and Mining

Gränges (OM:GRNG) Valuation: Assessing Fair Value After Q3 Sales Growth and Mixed Outlook

Gränges (OM:GRNG) just released its third quarter earnings, revealing a jump in sales but a dip in net income compared to last year. The company also shared its outlook for the coming quarter, projecting ongoing sales volume growth even though demand in key markets remains soft. See our latest analysis for Gränges. Gränges has seen its share price steadily build momentum, most notably with a 16.3% share price return over the past month and a 6.2% climb in the last quarter, as investors weigh...
OM:OVZON
OM:OVZONTelecom

Ovzon (OM:OVZON) Faces Valuation Pressure Despite Strong Forecasted Revenue and Earnings Growth

Ovzon (OM:OVZON) remains unprofitable but has managed to shrink its losses by 2.6% per year over the past five years. Looking ahead, revenue is forecast to rise 17.4% annually, far outpacing Sweden's broader market average of 3.8%, while earnings are projected to surge 78.47% per year, with profitability expected within three years. Despite these promising growth metrics, Ovzon’s price-to-sales ratio sits at 6.3x, which is significantly higher than both peer and industry averages and will...
OM:HEM
OM:HEMInteractive Media and Services

Hemnet Group (OM:HEM) Valuation Review Following Q3 Results and Share Buyback Completion

Hemnet Group (OM:HEM) just released its third quarter and nine-month results. Quarterly sales and net income dipped compared to last year, but nine-month numbers showed improvement. The company also wrapped up its latest share buyback tranche. See our latest analysis for Hemnet Group. Hemnet Group’s share price has lost momentum in recent months, with a 30-day share price return of -7% and a sharp 90-day drop of -26.2%. This reflects shifting sentiment after the buyback completion and a...
OM:HEXA B
OM:HEXA BElectronic

Did Hexagon's (OM:HEXA B) EcoSys Integration Lay Groundwork for Stronger Recurring Software Revenue?

Hexagon's Asset Lifecycle Intelligence division and Management Controls Inc. recently announced the launch of the EcoSys + myTrack Connector, an integration providing real-time contractor cost data directly within Hexagon’s project performance platform. This solution automates contractor data processes, aiming to streamline financial controls and forecasting for customers managing complex industrial and infrastructure projects worldwide. We'll explore how this new automation-focused product...
OM:WALL B
OM:WALL BReal Estate

How Investors May Respond To Wallenstam (OM:WALL B) Returning to Profitability After Last Year's Loss

Wallenstam recently reported strong third-quarter and nine-month results, with SEK 759 million in sales and SEK 682 million in net income, a reversal from a net loss the previous year. These results reflect a significant improvement in both operational performance and profitability, highlighting Wallenstam's ability to convert project execution and disciplined management into earnings growth. We'll examine how Wallenstam's return to profitability after last year's loss could shape its...
OM:HUSQ B
OM:HUSQ BMachinery

Husqvarna (OM:HUSQ B): Assessing Valuation Following Factory Closure Plans and Profitability Shift

Husqvarna (OM:HUSQ B) recently announced plans to close its Brastad factory as part of a shift toward a more flexible and asset-light business model, aiming for significant cost savings in the process. See our latest analysis for Husqvarna. The Brastad factory closure comes shortly after Husqvarna’s latest quarterly earnings, which showed narrowing losses even as sales dipped. Despite these moves to streamline and cut costs, sentiment has yet to turn, with a year-to-date share price return of...
OM:ALIG
OM:ALIGMachinery

Assessing Alimak Group (OM:ALIG) Valuation After Mixed Earnings and Recent Trading Volatility

Alimak Group (OM:ALIG) just released its Q3 earnings, highlighting a dip in quarterly sales and profits compared to last year. However, net income for the first nine months showed a solid improvement. See our latest analysis for Alimak Group. Alimak Group’s latest earnings update follows a stretch where momentum has clearly faded, with the share price down 12.3% over the past month and off 15.8% in the last quarter. Still, if you zoom out, the company’s total shareholder return is up an...
OM:BEIA B
OM:BEIA BMachinery

Is Beijer Alma (OM:BEIA B) Trading Margin Growth for Revenue Expansion?

Beijer Alma AB reported its third quarter and nine-month earnings for 2025, with sales rising to SEK 1,886 million in Q3 but net income dropping to SEK 176 million compared to last year. This combination of higher revenues but sharply lower profitability highlights pressure on the company’s margins and operational efficiency despite top-line growth. We’ll now examine how declining net income alongside sales growth may shape Beijer Alma’s broader investment narrative and future outlook. Trump...
OM:LAGR B
OM:LAGR BElectronic

Did Lagercrantz Group’s (OM:LAGR B) Strong Q2 Results Just Shift Its Investment Narrative?

Earlier this week, Lagercrantz Group AB reported earnings for the second quarter and first half of its fiscal year ended September 30, 2025, highlighting sales of SEK2,457 million and net income of SEK260 million for the quarter, both higher compared to the prior year. The company’s gains in both basic and diluted earnings per share for the period underscore a period of improved profitability and continued operational momentum. We'll now explore how Lagercrantz Group's year-over-year sales...
OM:BILL
OM:BILLPackaging

Billerud (OM:BILL): Assessing Valuation After Q3 Earnings Reveal Decline in Sales and Profitability

Billerud (OM:BILL) has published its Q3 earnings, showing a drop in sales and a shift from profit to net loss compared to last year. The results signal ongoing challenges and will be closely watched by investors. See our latest analysis for Billerud. Billerud’s latest Q3 results add to a year marked by changing fortunes. After drifting lower for much of 2024, the stock has staged a modest rebound recently, gaining 3.5% over the past month and 6.3% over the last 90 days. However, the...
OM:SCA B
OM:SCA BForestry

Will Lower Profitability Despite Higher Sales Reshape Svenska Cellulosa's (OM:SCA B) Margin Story?

Svenska Cellulosa Aktiebolaget SCA (publ) recently reported its third quarter and nine-month 2025 earnings, with quarterly sales of SEK4.99 billion and net income of SEK832 million, both lower than the same period last year. Despite higher sales over the nine months, overall profitability was down year-on-year, indicating that increased revenues did not fully translate into improved bottom-line results. We'll examine how the third quarter's decline in net income may influence SCA's...
OM:ADDT B
OM:ADDT BTrade Distributors

Rising Revenue and Earnings Could Be a Game Changer for Addtech AB (publ.) (OM:ADDT B)

Addtech AB (publ.) reported second quarter and six-month earnings results ended September 30, 2025, showing sales of SEK5.45 billion and SEK11.29 billion, respectively, with net income of SEK484 million for the quarter and SEK1.03 billion for the six months, both higher than the previous year. This marks a period of rising revenue and earnings, reflecting increased operational performance and potentially positive momentum in the company's ongoing activities. We'll explore the significance of...
OM:SEB A
OM:SEB ABanks

How Lower Fee and Commission Income at Skandinaviska Enskilda Banken (OM:SEB A) Has Changed Its Investment Story

Skandinaviska Enskilda Banken AB (SEB) recently reported that its third-quarter net income fell to SEK 7.68 billion, down from SEK 9.45 billion the previous year, with earnings per share also lower for both the quarter and the nine-month period ending September 30, 2025. The primary drivers of the earnings decline were lower net fee, commission, and financial income, offsetting a small increase in net interest income, while SEB maintained low credit costs and a cost-to-income ratio of...
OM:HPOL B
OM:HPOL BChemicals

A Look at HEXPOL (OM:HPOL B) Valuation After Reporting Declining Third Quarter Sales and Earnings

HEXPOL (OM:HPOL B) released its third quarter results, showing a decline in both sales and net income from the prior year. This earnings dip may prompt investors to reassess expectations for the months ahead. See our latest analysis for HEXPOL. HEXPOL’s latest earnings miss arrived as the company eyes new acquisitions and keeps sustainability front and center. After a tough start this year, the stock has begun to stabilize, with recent momentum edging upward, though its year-to-date share...
OM:CIBUS
OM:CIBUSReal Estate

Cibus Nordic Real Estate (OM:CIBUS): Valuation Insights Following Belgian Acquisition and Strategic Portfolio Shifts

Cibus Nordic Real Estate (OM:CIBUS) recently became the sole owner of One+ NV in Belgium, acquiring five fully-leased retail properties with a strong focus on grocery tenants. The company also launched a 50/50 joint venture with TS33 and sold non-strategic Belgian assets above book value, marking further portfolio shifts. See our latest analysis for Cibus Nordic Real Estate. Cibus Nordic Real Estate’s latest moves in Belgium have come during a year marked by wider portfolio optimization,...
OM:SOBI
OM:SOBIBiotechs

How Sobi’s Clinical Trial Results and FDA Approvals at ACR 2025 Will Impact (OM:SOBI) Investors

In October 2025, Swedish Orphan Biovitrum (Sobi) presented 15 scientific abstracts, including late-stage clinical trial results for Nanoencapsulated Sirolimus plus Pegadricase, Vonjo, and Gamifant, at the American College of Rheumatology (ACR) Convergence meeting in Chicago, with updates on both new safety data and recent US FDA approvals. The company highlighted its strengthened leadership in rare and underserved inflammatory conditions, with the presentation of advanced clinical data and...